NCT02204917View on ClinicalTrials.gov

CeVUS With Intravesical Administration of OPTISON TM (Trademark) in Children

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

March 31, 2016

Study Completion Date

March 31, 2017

Conditions
Vesico-Ureteral Reflux
Interventions
DRUG

OPTISON

Contrast enhanced Voiding Urosonography (ceVUS) with intravesical administration of OPTISON for vesicoureteral reflux detection and urethral imaging in children. Voiding Cystourethrography (VCUG) examination will be subsequently performed as part of the standard care.

Trial Locations (1)

19104

Department of Radiology, the Children's Hospital of Philadelphia, Philadelphia

All Listed Sponsors
lead

Kassa Darge

OTHER

NCT02204917 - CeVUS With Intravesical Administration of OPTISON TM (Trademark) in Children | Biotech Hunter | Biotech Hunter